A

Active Director Director DIN 07067094
DIN 07067094 First appointment Feb 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2015
Shareholding value •••• Premium profile

About Anbuvel

Data last updated:

Anbuvel is a Director at Xeno Life Science Private Limited (since 2015). The company operates in Pharma. Xeno Life Science Private Limited reported revenue of ₹86.7 Lakh (FY 2024).

DIN 07067094
Primary Designation Director
Industry Pharma
First Appointment 23 Feb 2015
Oldest Company Age 11 yrs
Largest company Xeno Life Science Private Limited · ₹86.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xeno Life Science Private Limited U74900TN2015PTC099340
Director23 Feb 20152015₹86.7 Lakh (FY 2024)Active

Board colleagues of Anbuvel

NameDINCompanyDesignation
Palani Vel Sakthivel02530330Xeno Life Science Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Xeno Life Science Private Limited
Premium access

Shareholding and investment profile for Anbuvel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anbuvel

Anbuvel currently holds 1 directorship: Xeno Life Science Private Limited (Director, since 23 Feb 2015, revenue ₹86.7 Lakh (FY 2024)).

Anbuvel was first appointed on 23 Feb 2015 as Director at Xeno Life Science Private Limited.

The current boards of Anbuvel's companies include Palani Vel Sakthivel (Xeno Life Science Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available